[7]
The patent at issue, Canadian Patent No. 1,304,080 ('080 patent), was issued to the Applicant, Daiichi, on June 23, 1992, which discloses and claims the antibiotic levofloxacin, known in North America as LEVAQUIN. The Canadian filing date of the '080 patent is June 19, 1986, and unless held to be invalid, the '080 patent will expire on June 23, 2009. The patent claims priority from three separate patent applications filed in Japan; the first on June 20, 1985 (Application No. 134712/85); the second on October 11, 1985 (Application No. 226499/85); and the third on January 28, 1986 (Application No. 16496/86).